First Merchants Corp’s iShares Biotechnology ETF IBB Stock Holding History

First Merchants Corp’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$344K	Sell	1,810 -27	-1%	-$4.64K	0.01%	286
2026 Q1	$310K	Sell	1,837 -168	-8%	-$28.7K	0.01%	294
2025 Q4	$338K	Sell	2,005 -2,110	-51%	-$343K	0.01%	300
2025 Q3	$594K	Sell	4,115 -1,268	-24%	-$173K	0.02%	252
2025 Q2	$681K	Hold	5,383	–	–	0.03%	242
2025 Q1	$688K	Sell	5,383 -150	-3%	-$20.3K	0.03%	244
2024 Q4	$732K	Sell	5,533 -75	-1%	-$10.5K	0.03%	252
2024 Q3	$817K	Sell	5,608 -175	-3%	-$25.3K	0.03%	248
2024 Q2	$794K	Sell	5,783 -4,470	-44%	-$597K	0.03%	244
2024 Q1	$1.41M	Sell	10,253 -30	-0.3%	-$4.1K	0.11%	139
2023 Q4	$1.4M	Sell	10,283 -39	-0.4%	-$4.76K	0.11%	135
2023 Q3	$1.26M	Sell	10,322 -150	-1%	-$19.1K	0.11%	143
2023 Q2	$1.33M	Sell	10,472 -7	-0.1%	-$909	0.11%	142
2023 Q1	$1.35M	Sell	10,479 -150	-1%	-$19.6K	0.12%	143
2022 Q4	$1.4M	Sell	10,629 -61	-0.6%	-$7.88K	0.13%	144
2022 Q3	$1.25M	Hold	10,690	–	–	0.13%	146
2022 Q2	$1.26M	Hold	10,690	–	–	0.12%	155
2022 Q1	$1.39M	Buy	10,690 +40	+0.4%	+$5.21K	0.11%	156
2021 Q4	$1.63M	Buy	10,650 +500	+5%	+$77.4K	0.13%	153
2021 Q3	$1.64M	Sell	10,150 -15	-0.1%	-$2.52K	0.1%	151
2021 Q2	$1.66M	Buy	10,165 +5	+0%	+$770	0.11%	150
2021 Q1	$1.53M	Buy	10,160 +10	+0.1%	+$1.59K	0.1%	152
2020 Q4	$1.54M	Sell	10,150 -290	-3%	-$41.4K	0.11%	147
2020 Q3	$1.41M	Sell	10,440 -155	-1%	-$21K	0.11%	143
2020 Q2	$1.45M	Sell	10,595 -1,550	-13%	-$198K	0.12%	137
2020 Q1	$1.31M	Sell	12,145 -75	-0.6%	-$8.63K	0.17%	135
2019 Q4	$1.47M	Hold	12,220	–	–	0.15%	145
2019 Q3	$1.22M	Sell	12,220 -251	-2%	-$26.3K	0.13%	165
2019 Q2	$1.36M	Sell	12,471 -1,174	-9%	-$125K	0.22%	121
2019 Q1	$1.52M	Buy	13,645 +25	+0.2%	+$2.74K	0.25%	113
2018 Q4	$1.31M	Sell	13,620 -580	-4%	-$61.6K	0.25%	116
2018 Q3	$1.73M	Sell	14,200 -25	-0.2%	-$2.94K	0.28%	106
2018 Q2	$1.56M	Hold	14,225	–	–	0.27%	107
2018 Q1	$1.52M	Sell	14,225 -2,346	-14%	-$260K	0.25%	105
2017 Q4	$1.77M	Sell	16,571 -2,005	-11%	-$214K	0.3%	97
2017 Q3	$2.06M	Hold	18,576	–	–	0.36%	84
2017 Q2	$1.92M	Hold	18,576	–	–	0.53%	66
2017 Q1	$1.82M	Buy	18,576 +1,041	+6%	+$99.7K	0.51%	68
2016 Q4	$1.55M	Hold	17,535	–	–	0.46%	75
2016 Q3	$1.69M	Hold	17,535	–	–	0.54%	64
2016 Q2	$1.5M	Sell	17,535 -1,902	-10%	-$171K	0.5%	67
2016 Q1	$1.69M	Buy	19,437 +480	+3%	+$42.9K	0.6%	62
2015 Q4	$2.14M	Sell	18,957 -1,110	-6%	-$120K	0.75%	45
2015 Q3	$2.03M	Sell	20,067 -12	-0.1%	-$1.44K	0.72%	52
2015 Q2	$2.47M	Sell	20,079 -348	-2%	-$41.7K	0.77%	43
2015 Q1	$2.34M	Sell	20,427 -1,014	-5%	-$112K	0.72%	48
2014 Q4	$2.17M	Sell	21,441 -1,200	-5%	-$117K	0.68%	55
2014 Q3	$2.06M	Sell	22,641 -948	-4%	-$83.2K	0.66%	62
2014 Q2	$2.02M	Sell	23,589 -3,051	-11%	-$240K	0.63%	61
2014 Q1	$2.1M	Buy	26,640 +684	+3%	+$57K	0.68%	54
2013 Q4	$1.96M	Sell	25,956 -450	-2%	-$31.9K	0.65%	61
2013 Q3	$1.84M	Sell	26,406 -450	-2%	-$29.5K	0.63%	63
2013 Q2	$1.56M	Buy	+26,856	New	+$1.55M	0.55%	69

Other funds holding IBB

Generali Investments CEE Prague, Czech Republic $2.11B AUM 25.53% 1-Year Est. Return

Folger Nolan Fleming Douglas Capital Management Washington, District of Columbia $1.22B AUM 34.81% 1-Year Est. Return

Apella Capital West Hartford, Connecticut $7.08B AUM 17.38% 1-Year Est. Return

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

Toth Financial Advisory Leesburg, Virginia $1.02B AUM 28.36% 1-Year Est. Return

Neville Rodie & Shaw New York $1.55B AUM 46.95% 1-Year Est. Return

McCollum Christoferson Group Amherst, New York $341M AUM 15.01% 1-Year Est. Return

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Southern Capital Advisors Jackson, Tennessee $239M AUM 22.42% 1-Year Est. Return

Howard Capital Management Group Los Angeles, California $1.64B AUM 24.96% 1-Year Est. Return